Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.06% Nasdaq Down0.01%

Optimer Pharmaceuticals, Inc. (OPTR)

-NasdaqGS

14.48 Down 0.19(1.30%) May 24, 4:00PM EDT|After Hours : 14.48 Up 0.00 (0.02%) May 24, 4:36PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 19,435   19,516   17,876   49,758  
Cost of Revenue3,291  3,017  2,635  4,014  
Gross Profit 16,145   16,499   15,241   45,744  
Operating Expenses
Research Development9,886  11,867  10,710  11,557  
Selling General and Administrative37,750  34,952  30,802  33,859  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (31,491) (30,320) (26,272) 328  
Income from Continuing Operations
Total Other Income/Expenses Net159  31,321  196  44  
Earnings Before Interest And Taxes(31,332)1,001  (26,076)373  
Interest Expense -   -   -   -  
Income Before Tax(31,332)1,001  (26,076)373  
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(31,332)1,001  (26,771)(296)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (31,332) 1,001   (26,771) (296)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (31,332) 1,001   (26,771) (296)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.